Alector Inc (ALEC)
5.56
+0.23
(+4.32%)
USD |
NASDAQ |
May 15, 14:38
Alector Enterprise Value: -48.35M for May 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 14, 2024 | -48.35M |
| May 13, 2024 | -42.57M |
| May 10, 2024 | -56.06M |
| May 09, 2024 | -60.88M |
| May 08, 2024 | -61.85M |
| May 07, 2024 | -51.24M |
| May 06, 2024 | -49.32M |
| May 03, 2024 | -42.57M |
| May 02, 2024 | -47.39M |
| May 01, 2024 | -53.17M |
| April 30, 2024 | -72.45M |
| April 29, 2024 | -55.10M |
| April 26, 2024 | -56.06M |
| April 25, 2024 | -98.47M |
| April 24, 2024 | -56.06M |
| April 23, 2024 | -47.39M |
| April 22, 2024 | -63.77M |
| April 19, 2024 | -71.49M |
| April 18, 2024 | -71.49M |
| April 17, 2024 | -73.41M |
| April 16, 2024 | -50.28M |
| April 15, 2024 | -18.47M |
| April 12, 2024 | 18.15M |
| April 11, 2024 | 38.39M |
| April 10, 2024 | 1.767M |
| Date | Value |
|---|---|
| April 09, 2024 | 21.04M |
| April 08, 2024 | -2.088M |
| April 05, 2024 | 0.8031M |
| April 04, 2024 | -6.908M |
| April 03, 2024 | 5.622M |
| April 02, 2024 | -1.125M |
| April 01, 2024 | 31.65M |
| March 31, 2024 | 18.15M |
| March 28, 2024 | 27.55M |
| March 27, 2024 | 33.29M |
| March 26, 2024 | 21.80M |
| March 25, 2024 | 22.76M |
| March 22, 2024 | 23.72M |
| March 21, 2024 | 47.66M |
| March 20, 2024 | 46.70M |
| March 19, 2024 | 44.78M |
| March 18, 2024 | 25.63M |
| March 15, 2024 | 37.12M |
| March 14, 2024 | 30.42M |
| March 13, 2024 | 45.74M |
| March 12, 2024 | 15.10M |
| March 11, 2024 | 65.85M |
| March 08, 2024 | 86.91M |
| March 07, 2024 | 81.17M |
| March 06, 2024 | 107.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-271.67M
Minimum
Nov 13 2023
2.840B
Maximum
Jul 07 2021
601.39M
Average
560.29M
Median
Enterprise Value Benchmarks
| AbbVie Inc | 341.32B |
| NovaBay Pharmaceuticals Inc | 3.698M |
| Palatin Technologies Inc | 29.40M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -8.844M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.08M |
| Revenue (Quarterly) | 15.89M |
| Total Expenses (Quarterly) | 59.60M |
| EPS Diluted (Quarterly) | -0.38 |
| Profit Margin (Quarterly) | -227.0% |
| Earnings Yield | -24.82% |
| Normalized Earnings Yield | -24.82 |